相关实验视频

Updated: Feb 19, 2026

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing

Published on: September 25, 2011

一个基于网络的IBD和结肠直肠癌的协会,使用蛋白质学数据

Jaiya Dhami¹, Swarnima Kollampallath Radhakrishnan¹, Dominic Russ^1,2,3

¹Cancer and Genomic Sciences, School of Medical Sciences, College of Medicine and Health, University of, Birmingham, UK.

Proteomics. Clinical applications

|February 18, 2026

概括

由炎性肠病 (IBD) 引起的慢性炎症与结直肠癌 (CRC) 共享分子通路. 这项研究确定了关键的蛋白质和调节剂,将这些条件联系起来,帮助早期检测和预防.

科学领域:

在瘤学瘤学.
胃肠病学胃肠病学
分子生物学分子生物学
生物信息学是一种生物信息学.

背景情况:

结肠直肠癌 (CRC) 构成重大健康风险,炎症性肠病 (IBD) 是已知的危险因素.
了解IBD和CRC之间的共同分子机制对于开发有效的早期检测和预防策略至关重要.

研究的目的:

阐明IBD和CRC之间共享的分子机制.
确定关键蛋白质和调节途径,参与由炎症驱动的结直肠癌发生.

主要方法:

用奥林克近距离延伸试验对七种CRC相关蛋白质进行英国生物库数据的蛋白质组分析.
在CRC和IBD病例中的蛋白质表达水平与对照者的比较.
使用Omics.Net构建多层相互作用网络 (蛋白质-蛋白质,蛋白质-代谢物,转录因子-蛋白质).
使用Colonomics转录基因数据集验证发现.

主要成果:

分析了7种与CRC相关的蛋白质;其中6种在CRC和IBD中都升高.
网络分析强调了AHCY和LCN2作为连接炎症和代谢途径的中心枢纽.
确定NF-κB和GATA2是复发的转录调节剂.
结肠学数据验证了CRC组织中AHCY,LCN2和SELE的上调.

结论:

在IBD和CRC之间存在着共同的分子框架.
炎症在结直肠癌发生过程中发挥着关键作用.
这些发现提供了对潜在的治疗点和生物标志物的洞察力,用于预防和早期检测IBD患者的CRC.

关键词:

IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD 英国-生物银行结肠癌是什么意思结肠癌是什么意思网络分析网络分析俄米克斯 (omicsics) 是一个电子产品.

更多相关视频

Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts

Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts

Published on: April 29, 2014

A Clinical Metaproteomics Workflow Implemented within Galaxy Bioinformatics Platform to Analyze Host-Microbiome Interactions Underlying Human Disease

A Clinical Metaproteomics Workflow Implemented within Galaxy Bioinformatics Platform to Analyze Host-Microbiome Interactions Underlying Human Disease

Published on: January 10, 2025

相关概念视频

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

Inflammatory Bowel Disease II: Crohn's Disease

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...

Inflammatory Bowel Disease I: Ulcerative Colitis

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...